Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Loef, E J
Title
Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses.
Citation
The Journal of biological chemistry; 2022 Jul; 298(7) pg102112
PubMed ID
35690148
Show Usages
Product Cited
Cross-Reactivity
Applications
200-04
Human
in vitro
300-23
Human
in vitro
200-01B
Human
in vitro
200-06
Human
in vitro
300-01A
Human
in vitro
300-35
Human
in vitro
200-07
Human
in vitro
200-12p80H
Human
in vitro
200-21
Human
in vitro
First Author
Varchetta, S
Title
Unique immunological profile in patients with COVID-19
Citation
Cellular & molecular immunology; 2021 Mar; 18(3) pg604-612
PubMed ID
33060840
Show Usages
Product Cited
Cross-Reactivity
Applications
200-12p80H
Human
in vitro
First Author
Zimmer, C
Title
NK cells are activated and primed for skin-homing during acute dengue virus infection in humans.
Citation
Nature Communications;2019 8 29; 10(1) pg3897
PubMed ID
31467285
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-200-02
Human
in vitro
200-12p80H
Human
in vitro
AF-200-15
Human
in vitro
First Author
Mace, T
Title
Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function.
Citation
Scientific Reports;2019 3 25; 9(1) pg5068
PubMed ID
30911044
Show Usages
Product Cited
Cross-Reactivity
Applications
200-12p80H
Human
in vitro
First Author
Collins, P L
Title
Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells.
Citation
Cell; 2019 Jan 10; 176(1-2) pg348-360.e12
PubMed ID
30595449
Show Usages
Product Cited
Cross-Reactivity
Applications
200-12p80H
Human
in vitro
First Author
Munir, S
Title
Characterization of T-cell responses against IκBα in cancer patients.
Citation
Oncoimmunology; 2012 Nov 1; 1(8) pg1290-1296
PubMed ID
23243592
Show Usages
Product Cited
Cross-Reactivity
Applications
200-07
Human
in vitro
200-12
Human
in vitro
200-12p80H
Human
in vitro
200-02
Human
in vitro
AF-200-07
Human
in vitro
200-12p40
Human
in vitro
AF-200-02
Human
in vitro
First Author
Domaica, C I
Title
Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
Citation
PLoS ONE; 2012; 7(12) pge51677
PubMed ID
23240056
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
200-12
Human
in vitro
200-12p80H
Human
in vitro
200-15
Human
in vitro
AF-200-02
Human
in vitro
200-12p40
Human
in vitro
AF-200-15
Human
in vitro
First Author
Mandapathil, M
Title
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma.
Citation
Oncoimmunology; 2012 Aug 1; 1(5) pg659-669
PubMed ID
22934258
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
200-12
Human
in vitro
200-12p80H
Human
in vitro
AF-200-02
Human
in vitro
200-10
Human
in vitro
200-12p40
Human
in vitro
First Author
Qi, Y
Title
The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin.
Citation
PLoS ONE; 2012; 7(6) pge39072
PubMed ID
22720031
Show Usages
Product Cited
Cross-Reactivity
Applications
AF-200-02
Human
in vitro
200-12p40
Human
in vitro
200-02
Human
in vitro
200-12
Human
in vitro
200-12p80H
Human
in vitro
First Author
Macdonald, S H
Title
Networked T cell death following macrophage infection by Mycobacterium tuberculosis.
Citation
PLoS ONE; 2012; 7(6) pge38488
PubMed ID
22675566
Show Usages
Product Cited
Cross-Reactivity
Applications
200-12p40
Human
in vitro
200-12
Human
in vitro
200-12p80H
Human
in vitro
showing 10 of 12
Show More